NEW YORK (GenomeWeb) – OpGen after the close of the market Wednesday reported a 128 percent increase in its first quarter revenues.

For the three months ended March 31, the Gaithersburg, Maryland-based infectious disease testing and bioinformatics firm reported revenues of $1.1 million, up from $472,200 in the first quarter of 2015. The rise is attributable to sales of AdvanDx diagnostic products and CLIA laboratory services provided using the Acuitas multi-drug resistant organisms testing suite, OpGen Chairman and CEO Evan Jones said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.